Repeated heart rate measurement and cardiovascular outcomes in left ventricular systolic dysfunction

American Journal of Medicine

Volumn 128, Issue 10, 2015, Pages 1102-1108.e6

  Hamill, Victoria ^a   Ford, Ian ^a   Fox, Kim ^b   Böhm, Michael ^c   Borer, Jeffrey S ^d   Ferrari, Roberto ^e   Komajda, Michel ^f   Steg, Philippe Gabriel ^b,g,h   Tavazzi, Luigi ⁱ   Tendera, Michal ^j   Swedberg, Karl ^b,k  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c Klinik Für Innere Medizin III Kardiologie Angiologie und Internistische Intensivmedizin   (Germany)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^f SORBONNE UNIVERSITÉ   (France)

^g BICHAT HOSPITAL   (France)

^h Site Xavier Bichat and Département Hospitalo Universitaire Fibrosis Inflammation and Remodeling   (France)

ⁱ Research Ettore Sansavini Health Science Foundation   (Italy)

^j MEDICAL UNIVERSITY OF SILESIA   (Poland)

^k SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

BEAUTIFUL; Heart rate; Left ventricular systolic dysfunction; Prognosis; SHIFT

Indexed keywords

IVABRADINE; PLACEBO;

AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEART BEAT; HEART INFARCTION; HEART RATE; HOSPITALIZATION; HUMAN; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC HEART FAILURE; ADULT; COMPLICATION; EVALUATION STUDY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; TIME;

ADULT; AGED; FEMALE; HEART FAILURE; HEART RATE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84941760377     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2015.04.042     Document Type: Article

References (14)

1. K. Fox, J.S. Borer, A.J. Camm, and et al. Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 2007 823 830
2. K. Swedberg, M. Komajda, M. Böhm, and et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled trial Lancet 376 2010 875 885
3. K. Fox, I. Ford, P.G. Steg, M. Tendera, M. Robertson, and R. Ferrari Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 2008 817 821
4. M. Bohm, K. Swedberg, M. Komajda, and et al. Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet 376 2010 886 894
5. R. Ferrari, I. Ford, K. Fox, P.G. Steg, and M. Tendera The BEAUTIFUL study: randomized trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction-baseline characteristics of the study population Cardiology 110 2008 271 282
6. K. Swedberg, M. Komajda, M. Böhm, J.S. Borer, I. Ford, and L. Tavazzi Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f)Inhibitor Ivabradine Trial (SHIFT) Eur J Heart Fail 12 2010 75 81
7. A. Vazir, B. Claggett, P. Jhund, and et al. Prognostic importance of temporal changes in resting heart rate in heart failure patients: an analysis of the CHARM program Eur Heart J 36 2015 669 675
8. W.B. Kannel, C. Kannel, R.S.J.R. Paffenbarger, and L.A. Cupples Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1987 1489 1494
9. R. Kolloch, U.F. Legler, A. Champion, and et al. Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST) Eur Heart J 29 2008 1327 1334
10. J.C. Reil, J.C. Tardif, I. Ford, and et al. Selective heart rate reduction with ivabradine unloads the left ventricle in heart failure patients J Am Coll Cardiol 62 2013 1977 1985
11. J.C. Reil, F. Custodis, K. Swedberg, and et al. Heart rate reduction in cardiovascular disease and therapy Clin Res Cardiol 100 2011 11 19
12. C.W. Yancy, M. Jessup, B. Bozkurt, and et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 2013 e147 e239
13. J.J. McMurray, S. Adamopoulos, S.D. Anker, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur J Heart Fail 14 2012 803 869
14. K. Fox, M. Komajda, I. Ford, and et al. Effect of ivabradine in patients with left-ventricular systolic dysfunction: a pooled analysis of individual patient data from the BEAUTIFUL and SHIFT trials Eur Heart J 34 2013 2263 2270